A6527012
Orotic Acid Monohydrate , 98% , 50887-69-9
Synonym(s):
2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid
CAS NO.：50887-69-9
Empirical Formula: C5H6N2O5
Molecular Weight: 174.11
MDL number: MFCD00149398
EINECS: 610-580-2
| Pack Size | Price | Stock | Quantity |
| 25G | RMB51.20 | In Stock |
|
| 100G | RMB94.40 | In Stock |
|
| 500G | RMB372.80 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | >300 °C(lit.) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | Aqueous Base (Slightly), DMSO (Slightly) |
| form | Crystalline Powder |
| color | White to off-white |
| Water Solubility | Soluble in water (1.7 mg/ml), and ammonium hydroxide. Insoluble in chloroform. |
| Merck | 14,6876 |
| BRN | 383901 |
| InChI | InChI=1S/C5H4N2O4.H2O/c8-3-1-2(4(9)10)6-5(11)7-3;/h1H,(H,9,10)(H2,6,7,8,11);1H2 |
| InChIKey | YXUZGLGRBBHYFZ-UHFFFAOYSA-N |
| SMILES | C1(C(=O)O)NC(NC(=O)C=1)=O.O |
Description and Uses
Orotic Acid is used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| WGK Germany | 3 |
| RTECS | RM3180000 |
| TSCA | Yes |
| HS Code | 29335990 |
